SCHEMBL5835936

SCHEMBL5835936

CCN(CC)c1ccc(NC(=O)N(C(=O)OCC(C)C)C2CCc3cccc(OC)c3C2)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 2/20 0.50
KCNH2 Q12809 1/20 0.50
MAPT P10636 8/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPK1 P28482 3/20 0.49
GFER P55789 3/20 0.49
NPSR1 Q6W5P4 1/20 0.49
LMNA P02545 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HSD17B10 Q99714 2/20 0.43
ALOX15 P16050 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 2/20 0.42
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835072 0.89 GHSR (0.60) GHSRKCNH2MAPTALOX15CHRM2
SCHEMBL5835177 0.79 GHSR (0.50) GHSRKCNH2MAPTRAB9A
SCHEMBL5835215 0.77 GHSR (0.80) GHSRKCNH2MAPTALDH1A1MAPK1
SCHEMBL5835145 0.77 GHSR (0.55) GHSRKCNH2MAPTALDH1A1MAPK1
SCHEMBL5835564 0.76 GHSR (0.46) GHSRMAPTALDH1A1MAPK1GFER
SCHEMBL5835928 0.75 GHSR (0.65) GHSRKCNH2MAPTALDH1A1MAPK1
SCHEMBL5836100 0.75 GHSR (0.49) GHSRMAPTALDH1A1MAPK1GFER
SCHEMBL5834802 0.69 GHSR (0.59) GHSRMAPTALDH1A1MAPK1GFER
SCHEMBL5834865 0.69 MAPT (0.56) GHSRKCNH2MAPTALDH1A1MAPK1
SCHEMBL5835352 0.67 GHSR (0.71) GHSRKCNH2MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885MAPT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.